The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cabozantinib plus atezolizumab in patients with advanced and progressive neuroendocrine neoplasms (NENs): A prospective multi-cohort basket phase II trial (CABATEN / GETNE-T1914).
 
Jorge Hernando
Speakers' Bureau - Advanced Accelerator Applications; Angelini Pharma; Bayer; Eisai; Ipsen; Novartis; Roche
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Eisai; Ipsen; Novartis; Roche
 
Javier Molina-Cerrillo
Consulting or Advisory Role - Advanced Accelerator Applications; Eisai; Ipsen; Janssen; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Ipsen; Pfizer
Research Funding - Ipsen; Pfizer
Travel, Accommodations, Expenses - Ipsen
 
Enrique Grande
Honoraria - Abbott/AbbVie; Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; AVEO; Bristol-Myers Squibb; Dr. Reddy's Laboratories; Eisai; Eusa Pharma; EUSA Pharma; GlaxoSmithKline; IPSEN; Janssen-Cilag; Lilly; Merck KGaA; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Abbvie; AVEO; Bristol-Myers Squibb; Gilead Sciences; Ipsen; MSD; Pfizer; Roche; Roche
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ipsen (Inst); Lexicon (Inst); Merck KGaA (Inst); Molecular Templates (Inst); Pfizer (Inst); Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Pfizer; Roche/Genentech
 
Marta Benavent Viñuales
Consulting or Advisory Role - Ipsen; Novartis; Pfizer
Travel, Accommodations, Expenses - Ipsen; Novartis; Pfizer
 
Rocio Garcia-Carbonero
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Pharma; Astellas Pharma; AstraZeneca (I); Bayer; BMS; Boehringer Ingelheim; Esteve; Gilead Sciences (I); Hutchmed; Ipsen; Lilly (I); Merck; Midatech Pharma; Mirati Therapeutics (I); MSD; Pfizer (I); PharmaMar; Roche (I); Sanofi (I); Servier; Takeda
Research Funding - BMS (Inst); MSD (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Advanced Accelerator Applications/Novartis; Esteve; Ipsen; Merck; MSD
 
Alex Teule
Honoraria - AAA HealthCare; Esteve; Ipsen; Novartis
Consulting or Advisory Role - AAA HealthCare; Esteve
Travel, Accommodations, Expenses - AAA/Endocyte/Novartis
 
Ana Custodio
No Relationships to Disclose
 
Paula Jimenez-Fonseca
Speakers' Bureau - BMS GmbH & Co. KG; Lilly
Other Relationship - IPSEN
 
Cinta Hierro
Speakers' Bureau - MSD
Research Funding - Bayer (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Amgen; Merck
 
Carlos López López
Honoraria - Advanced Accelerator Applications; AstraZeneca; Bayer; Bristol Myers Squibb; Eisai; Ipsen; Merck; MSD Oncology; Novartis; Pfizer; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Eisai; Ipsen; Merck; Pfizer; Roche; Sanofi; SERVIER
Research Funding - Amgen; AstraZeneca Spain; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Ipsen; Merck; Merck Sharp & Dohme; Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; Ipsen; Merck; Pfizer; Roche; SERVIER
 
Isabel Sevilla
No Relationships to Disclose
 
Marta Llanos
Honoraria - Bristol-Myers Squibb; Eisai; Ipsen; Ipsen; Lilly; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Roche
 
Alberto Carmona-Bayonas
Consulting or Advisory Role - Pfizer; Roche/Genentech
Speakers' Bureau - ROVI
Research Funding - Leo Pharma
Travel, Accommodations, Expenses - Ipsen; Novartis; Roche/Genentech
 
Vicente Alonso
Consulting or Advisory Role - Amgen; Ipsen; Merck Serono; Novartis; Pierre Fabre; Sanofi/Regeneron; SERVIER
Travel, Accommodations, Expenses - Amgen; Ipsen; Merck Serono; Novartis; Sanofi/Regeneron; SERVIER
 
Javier Gallego
Consulting or Advisory Role - AAA HealthCare; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Eisai Europe; Lilly; Merck Serono; Roche
Speakers' Bureau - Amgen; Ipsen; Lilly; Novartis
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Lilly; Merck
Travel, Accommodations, Expenses - Amgen; Novartis; Roche
Other Relationship - Amgen; Amgen; Bristol-Myers Squibb
 
Inmaculada Gallego Jiménez
No Relationships to Disclose
 
Alberto Orta
No Relationships to Disclose
 
Fernando Franco
No Relationships to Disclose
 
Alejandro García-Álvarez
Speakers' Bureau - Angelini Pharma; Company: Eisai Europe; Eisai
Travel, Accommodations, Expenses - Advanced Accelerator Applications/Novartis; Advanz Pharma; Advanz Pharma; Amgen; Eisai Europe; Ipsen; Pfizer
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Esteve; Exelixis; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Roche/Genentech; Sanofi
Speakers' Bureau - Bayer; Eisai; Esteve; Hutchison MediPharma; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Gilead Sciences (Inst); Ipsen (Inst); Ipsen (Inst); ITM Solucin (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Eisai; Gilead Sciences; Ipsen; Pfizer